Non-Small-Cell Lung Cancer Patients with a High Predicted Risk of Irradical Resection: Can Chemoradiotherapy Offer Similar Survival?

PURPOSE: Irradical resection of non-small-cell lung cancer (NSCLC) is a detrimental prognostic factor. Recently, Rasing et al. presented an internationally validated risk score for pre-treatment prediction of irradical resection. We hypothesized that chemoradiation therapy (CRT) could serve as an al...

Descripción completa

Detalles Bibliográficos
Autores principales: van Joolingen, W. Hugo, Rasing, Marnix J. A., Peters, Max, van Lindert, Anne S. R., de Heer, Linda M., Aarts, Mieke J., Verhoeff, Joost J. C., van Rossum, Peter S. N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Thoracic Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810471/
https://www.ncbi.nlm.nih.gov/pubmed/34718916
http://dx.doi.org/10.1245/s10434-021-10982-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810471/
https://www.ncbi.nlm.nih.gov/pubmed/34718916
http://dx.doi.org/10.1245/s10434-021-10982-3

Ejemplares similares